Download PDF
Semin Reprod Med 2007; 25(4): 225-234
DOI: 10.1055/s-2007-980216
Copyright © 2007 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA.

Growth Factors in Ovarian Development

Stephanie A. Pangas1
  • 1Department of Pathology, Baylor College of Medicine, Houston, Texas
Further Information

Publication History

Publication Date:
26 June 2007 (online)

    Permissions and Reprints

ABSTRACT

Folliculogenesis in the adult ovary proceeds from quiescent primordial follicles through several developmental stages that culminate in the release of oocytes for fertilization and terminal differentiation of follicles into corpora lutea. Multiple developmental pathways control growth of oocytes and differentiation of somatic cells of the follicle. Growth factors of the transforming growth factor beta family play prominent roles during follicle development. Recent studies have begun to examine the role of additional developmentally important growth factor families, such as the Hedgehog, Wnt, and Notch families. This review summarizes recent developments on these signaling pathways in the adult mammalian ovary.

KEYWORDS

Fertility - reproduction - signal transduction

REFERENCES

  • 1 Eggan K, Jurga S, Gosden R, Min I M, Wagers A J. Ovulated oocytes in adult mice derive from non-circulating germ cells.  Nature. 2006;  441(7097) 1109-1114
    CrossrefPubMedGoogle Scholar
  • 2 Kumar T R, Matzuk M M. Gene knockout models to study the hypothalamus-pituitary-gonadal axis. In: Shupnik MA Gene Engineering and Molecular Models in Endocrinology. Totowa, NJ; Humana Press 2000
    Google Scholar
  • 3 Kumar T R, Palapattu G, Wang P et al.. Transgenic models to study gonadotropin function: the role of follicle-stimulating hormone in gonadal growth and tumorigenesis.  Mol Endocrinol. 1999;  13 851-865
    CrossrefPubMedGoogle Scholar
  • 4 Matzuk M M, Kumar T R, Vassalli A et al.. Functional analysis of activins in mammalian development.  Nature. 1995;  374 354-356
    PubMedGoogle Scholar
  • 5 Gougeon A. Dynamics of follicular growth in the human: a model from preliminary results.  Hum Reprod. 1986;  1 81-87
    PubMedGoogle Scholar
  • 6 Gougeon A. Ovarian follicular growth in humans: ovarian aging and populations of growing follicles.  Endocr Rev. 1996;  17(2) 121-155
    CrossrefPubMedGoogle Scholar
  • 7 Hirshfield A N. Development of follicles in the mammalian ovary.  Int Rev Cytol. 1991;  124 43-101
    PubMedGoogle Scholar
  • 8 Eppig J J. Oocyte control of ovarian follicular development and function in mammals.  Reproduction. 2001;  122(6) 829-838
    CrossrefPubMedGoogle Scholar
  • 9 Matzuk M M, Burns K, Viveiros M M, Eppig J. Intercellular communication in the mammalian ovary: oocytes carry the conversation.  Science. 2002;  296 2178-2180
    CrossrefPubMedGoogle Scholar
  • 10 Parrott J A, Skinner M K. Thecal cell-granulosa cell interactions involve a positive feedback loop among keratinocyte growth factor, hepatocyte growth factor, and kit ligand during ovarian follicular development.  Endocrinology. 1998;  139(5) 2240-2245
    CrossrefPubMedGoogle Scholar
  • 11 Matzuk M M, Lamb D J. Genetic dissection of mammalian fertility pathways.  Nat Cell Biol. 2002;  8(suppl 1) S41-S49
    PubMedGoogle Scholar
  • 12 Rajkovic A, Pangas S A, Matzuk M M. Follicular development: mouse, sheep and human models. In: Neill JD Physiology of Reproduction. 3rd ed. Volume 1. New York; Elsevier 2006: 383-423
    Google Scholar
  • 13 Pangas S A, Saudye H, Shea L D, Woodruff T K. Novel approach for the three-dimensional culture of granulosa cell-oocyte complexes.  Tissue Eng. 2003;  9(5) 1013-1021
    CrossrefPubMedGoogle Scholar
  • 14 Hubner K, Fuhrmann G, Christenson L K et al.. Derivation of oocytes from mouse embryonic stem cells.  Science. 2003;  300(5623) 1251-1256
    CrossrefPubMedGoogle Scholar
  • 15 Dyce P W, Wen L, Li J. In vitro germline potential of stem cells derived from fetal porcine skin.  Nat Cell Biol. 2006;  8(4) 384-390
    CrossrefPubMedGoogle Scholar
  • 16 Ghiglieri C, Khatchadourian C, Tabone E, Hendrick J C, Benahmed M, Menezo Y. Immunolocalization of transforming growth factor-beta 1 and transforming growth factor-beta 2 in the mouse ovary during gonadotrophin-induced follicular maturation.  Hum Reprod. 1995;  10(8) 2115-2119
    PubMedGoogle Scholar
  • 17 Erickson G F, Shimasaki S. The spatiotemporal expression pattern of the bone morphogenetic protein family in rat ovary cell types during the estrous cycle.  Reprod Biol Endocrinol. 2003;  1(1) 9-28
    CrossrefPubMedGoogle Scholar
  • 18 Pangas S A, Rademaker A W, Fishman D A, Woodruff T K. Localization of the activin signal transduction components in normal human ovarian follicles: implications for autocrine and paracrine signaling in the ovary.  J Clin Endocrinol Metab. 2002;  87(6) 2644-2657
    CrossrefPubMedGoogle Scholar
  • 19 Drummond A E, Le M T, Ethier J F, Dyson M, Findlay J K. Expression and localization of activin receptors, Smads, and beta glycan to the postnatal rat ovary.  Endocrinology. 2002;  143(4) 1423-1433
    CrossrefPubMedGoogle Scholar
  • 20 Pangas S A, Matzuk M M. Genetic models for transforming growth factor beta superfamily signaling in ovarian follicle development.  Mol Cell Endocrinol. 2004;  225(1-2) 83-91
    CrossrefPubMedGoogle Scholar
  • 21 Chen Y G, Hata A, Lo R S et al.. Determinants of specificity in TGF-beta signal transduction.  Genes Dev. 1998;  12(14) 2144-2152
    PubMedGoogle Scholar
  • 22 Dong J, Albertini D F, Nishimori K, Kumar T R, Lu N, Matzuk M M. Growth differentiation factor-9 is required during early ovarian folliculogenesis.  Nature. 1996;  383 531-535
    CrossrefPubMedGoogle Scholar
  • 23 Di Pasquale E, Beck-Peccoz P, Persani L. Hypergonadotropic ovarian failure associated with an inherited mutation of human bone morphogenetic protein-15 (BMP15) gene.  Am J Hum Genet. 2004;  75(1) 106-111
    CrossrefPubMedGoogle Scholar
  • 24 Galloway S M, McNatty K P, Cambridge L M et al.. Mutations in an oocyte-derived growth factor gene (BMP15) cause increased ovulation rate and infertility in a dosage-sensitive manner.  Nat Genet. 2000;  25(3) 279-283
    CrossrefPubMedGoogle Scholar
  • 25 Juengel J L, Hudson N L, Heath D A et al.. Growth differentiation factor 9 and bone morphogenetic protein 15 are essential for ovarian follicular development in sheep.  Biol Reprod. 2002;  67(6) 1777-1789
    CrossrefPubMedGoogle Scholar
  • 26 Wilson T, Wu X Y, Juengel J L et al.. Highly prolific Booroola sheep have a mutation in the intracellular kinase domain of bone morphogenetic protein IB receptor (ALK-6) that is expressed in both oocytes and granulosa cells.  Biol Reprod. 2001;  64(4) 1225-1235
    CrossrefPubMedGoogle Scholar
  • 27 Elvin J A, Yan C, Wang P, Nishimori K, Matzuk M M. Molecular characterization of the follicle defects in the growth differentiation factor-9-deficient ovary.  Mol Endocrinol. 1999;  13 1018-1034
    CrossrefPubMedGoogle Scholar
  • 28 Rajkovic A, Pangas S A, Ballow D, Suzumori N, Matzuk M M. NOBOX deficiency disrupts early folliculogenesis and oocyte-specific gene expression.  Science. 2004;  305(5687) 1157-1159
    CrossrefPubMedGoogle Scholar
  • 29 Dube J L, Wang P, Elvin J, Lyons K M, Celeste A J, Matzuk M M. The bone morphogenetic protein 15 gene is X-linked and expressed in oocytes.  Mol Endocrinol. 1998;  12 1809-1817
    CrossrefPubMedGoogle Scholar
  • 30 Mazerbourg S, Klein C, Roh J et al.. Growth differentiation factor-9 signaling is mediated by the type I receptor, activin receptor-like kinase 5.  Mol Endocrinol. 2004;  18(3) 653-665
    PubMedGoogle Scholar
  • 31 Moore R K, Otsuka F, Shimasaki S. Molecular basis of bone morphogenetic protein-15 signaling in granulosa cells.  J Biol Chem. 2003;  278(1) 304-310
    PubMedGoogle Scholar
  • 32 Liao W X, Moore R K, Otsuka F, Shimasaki S. Effect of intracellular interactions on the processing and secretion of bone morphogenetic protein-15 (BMP-15) and growth and differentiation factor-9. Implication of the aberrant ovarian phenotype of BMP-15 mutant sheep.  J Biol Chem. 2003;  278(6) 3713-3719
    CrossrefPubMedGoogle Scholar
  • 33 Carabatsos M J, Elvin J A, Matzuk M M, Albertini D F. Characterization of oocyte and follicle development in growth differentiation factor-9-deficient mice.  Dev Biol. 1998;  204 373-384
    CrossrefPubMedGoogle Scholar
  • 34 Yan C, Wang P, DeMayo J et al.. Synergistic roles of bone morphogenetic protein 15 and growth differentiation factor 9 in ovarian function.  Mol Endocrinol. 2001;  15(6) 854-866
    CrossrefPubMedGoogle Scholar
  • 35 McNatty K P, Lawrence S, Groome N P et al.. Meat and Livestock Association Plenary Lecture 2005. Oocyte signalling molecules and their effects on reproduction in ruminants.  Reprod Fertil Dev. 2006;  18(4) 403-412
    CrossrefPubMedGoogle Scholar
  • 36 McNatty K P, Smith P, Moore L G et al.. Oocyte-expressed genes affecting ovulation rate.  Mol Cell Endocrinol. 2005;  234(1-2) 57-66
    CrossrefPubMedGoogle Scholar
  • 37 Di Pasquale E, Rossetti R, Marozzi A et al.. Identification of new variants of human BMP15 gene in a large cohort of women with premature ovarian failure.  J Clin Endocrinol Metab. 2006;  91(5) 1976-1979
    CrossrefPubMedGoogle Scholar
  • 38 Dixit H, Rao L K, Padmalatha V V et al.. Missense mutations in the BMP15 gene are associated with ovarian failure.  Hum Genet. 2006;  119(4) 408-415
    CrossrefPubMedGoogle Scholar
  • 39 Dixit H, Rao L K, Padmalatha V et al.. Mutational screening of the coding region of growth differentiation factor 9 gene in Indian women with ovarian failure.  Menopause. 2005;  12(6) 749-754
    CrossrefPubMedGoogle Scholar
  • 40 Knight P G, Glister C. TGF-beta superfamily members and ovarian follicle development.  Reproduction. 2006;  132(2) 191-206
    CrossrefPubMedGoogle Scholar
  • 41 Chang H, Brown C W, Matzuk M M. Genetic analysis of the mammalian TGF-β superfamily.  Endocr Rev. 2002;  23 787-823
    CrossrefPubMedGoogle Scholar
  • 42 World Health Organization .Reproductive Health Strategy. Geneva; World Health Organization 2004
    Google Scholar
  • 43 Centers for Disease Control and Prevention .Assisted reproductive technology success rates: national summary and fertility clinic reports. Atlanta, GA; Centers for Disease Control and Prevention 2000
    Google Scholar
  • 44 Kobayashi A, Behringer R R. Developmental genetics of the female reproductive tract in mammals.  Nat Rev Genet. 2003;  4(12) 969-980
    CrossrefPubMedGoogle Scholar
  • 45 Visser J A, de Jong F H, Laven J S, Themmen A P. Anti-Mullerian hormone: a new marker for ovarian function.  Reproduction. 2006;  131(1) 1-9
    CrossrefPubMedGoogle Scholar
  • 46 Behringer R R. The in vivo roles of mullerian-inhibiting substance.  Curr Top Dev Biol. 1994;  29 171-187
    PubMedGoogle Scholar
  • 47 Durlinger A L, Kramer P, Karels B et al.. Control of primordial follicle recruitment by anti-Mullerian hormone in the mouse ovary.  Endocrinology. 1999;  140(12) 5789-5796
    CrossrefPubMedGoogle Scholar
  • 48 Durlinger A L, Gruijters M J, Kramer P et al.. Anti-Mullerian hormone inhibits initiation of primordial follicle growth in the mouse ovary.  Endocrinology. 2002;  143(3) 1076-1084
    CrossrefPubMedGoogle Scholar
  • 49 van Rooij I A, Broekmans F J, te Velde E R et al.. Serum anti-Mullerian hormone levels: a novel measure of ovarian reserve.  Hum Reprod. 2002;  17(12) 3065-3071
    CrossrefPubMedGoogle Scholar
  • 50 de Vet A, Laven J S, de Jong F H, Themmen A P, Fauser B C. Antimullerian hormone serum levels: a putative marker for ovarian aging.  Fertil Steril. 2002;  77(2) 357-362
    CrossrefPubMedGoogle Scholar
  • 51 Fanchin R, Schonauer L M, Righini C, Guibourdenche J, Frydman R, Taieb J. Serum anti-Mullerian hormone is more strongly related to ovarian follicular status than serum inhibin B, estradiol, FSH and LH on day 3.  Hum Reprod. 2003;  18(2) 323-327
    CrossrefPubMedGoogle Scholar
  • 52 Kevenaar M E, Meerasahib M F, Kramer P et al.. Serum anti-mullerian hormone levels reflect the size of the primordial follicle pool in mice.  Endocrinology. 2006;  147(7) 3228-3234
    CrossrefPubMedGoogle Scholar
  • 53 Bath L E, Wallace W H, Shaw M P, Fitzpatrick C, Anderson R A. Depletion of ovarian reserve in young women after treatment for cancer in childhood: detection by anti-Mullerian hormone, inhibin B and ovarian ultrasound.  Hum Reprod. 2003;  18(11) 2368-2374
    CrossrefPubMedGoogle Scholar
  • 54 Anderson R A, Themmen A P, Al-Qahtani A, Groome N P, Cameron D A. The effects of chemotherapy and long-term gonadotrophin suppression on the ovarian reserve in premenopausal women with breast cancer.  Hum Reprod. 2006;  21(10) 2583-2592
    CrossrefPubMedGoogle Scholar
  • 55 Laven J S, Mulders A G, Visser J A, Themmen A P, De Jong F H, Fauser B C. Anti-Mullerian hormone serum concentrations in normoovulatory and anovulatory women of reproductive age.  J Clin Endocrinol Metab. 2004;  89(1) 318-323
    CrossrefPubMedGoogle Scholar
  • 56 Cook C L, Siow Y, Brenner A G, Fallat M E. Relationship between serum mullerian-inhibiting substance and other reproductive hormones in untreated women with polycystic ovary syndrome and normal women.  Fertil Steril. 2002;  77(1) 141-146
    CrossrefPubMedGoogle Scholar
  • 57 Pigny P, Jonard S, Robert Y, Dewailly D. Serum anti-Mullerian hormone as a surrogate for antral follicle count for definition of the polycystic ovary syndrome.  J Clin Endocrinol Metab. 2006;  91(3) 941-945
    CrossrefPubMedGoogle Scholar
  • 58 Pellatt L, Hanna L, Brincat M et al.. Granulosa cell production of anti-Mullerian hormone is increased in polycystic ovaries.  J Clin Endocrinol Metab. 2006;  , In press
    PubMedGoogle Scholar
  • 59 Wozney J M. The bone morphogenetic protein family: multifunctional cellular regulators in the embryo and adult.  Eur J Oral Sci. 1998;  106(suppl 1) 160-166
    PubMedGoogle Scholar
  • 60 Shimasaki S, Moore R K, Otsuka F, Erickson G F. The bone morphogenetic protein system in mammalian reproduction.  Endocr Rev. 2004;  25(1) 72-101
    CrossrefPubMedGoogle Scholar
  • 61 Chen D, Zhao M, Mundy G R. Bone morphogenetic proteins.  Growth Factors. 2004;  22(4) 233-241
    Google Scholar
  • 62 Shimasaki S, Zachow R J, Li D et al.. A functional bone morphogenetic protein system in the ovary.  Proc Natl Acad Sci USA. 1999;  96 7282-7287
    CrossrefPubMedGoogle Scholar
  • 63 Nilsson E E, Skinner M K. Bone morphogenetic protein-4 acts as an ovarian follicle survival factor and promotes primordial follicle development.  Biol Reprod. 2003;  69(4) 1265-1272
    CrossrefPubMedGoogle Scholar
  • 64 Juengel J L, Reader K L, Bibby A H et al.. The role of bone morphogenetic proteins 2, 4, 6 and 7 during ovarian follicular development in sheep: contrast to rat.  Reproduction. 2006;  131(3) 501-513
    CrossrefPubMedGoogle Scholar
  • 65 Glister C, Richards S L, Knight P G. Bone morphogenetic proteins (BMP) - 4, - 6, and - 7 potently suppress basal and luteinizing hormone-induced androgen production by bovine theca interna cells in primary culture: could ovarian hyperandrogenic dysfunction be caused by a defect in thecal BMP signaling?.  Endocrinology. 2005;  146(4) 1883-1892
    CrossrefPubMedGoogle Scholar
  • 66 Glister C, Kemp C F, Knight P G. Bone morphogenetic protein (BMP) ligands and receptors in bovine ovarian follicle cells: actions of BMP-4, -6 and -7 on granulosa cells and differential modulation of Smad-1 phosphorylation by follistatin.  Reproduction. 2004;  127(2) 239-254
    CrossrefPubMedGoogle Scholar
  • 67 Yi S E, LaPolt P S, Yoon B S, Chen J Y, Lu J K, Lyons K M. The type I BMP receptor BmprIB is essential for female reproductive function.  Proc Natl Acad Sci USA. 2001;  98(14) 7994-7999
    CrossrefPubMedGoogle Scholar
  • 68 McDowell N, Gurdon J B. Activin as a morphogen in Xenopus mesoderm induction.  Semin Cell Dev Biol. 1999;  10(3) 311-317
    CrossrefPubMedGoogle Scholar
  • 69 Gurdon J B, Bourillot P Y. Morphogen gradient interpretation.  Nature. 2001;  413(6858) 797-803
    PubMedGoogle Scholar
  • 70 Podos S D, Ferguson E L. Morphogen gradients: new insights from DPP.  Trends Genet. 1999;  15(10) 396-402
    CrossrefPubMedGoogle Scholar
  • 71 Jones C M, Smith J C. Establishment of a BMP-4 morphogen gradient by long-range inhibition.  Dev Biol. 1998;  194(1) 12-17
    CrossrefPubMedGoogle Scholar
  • 72 Pangas S A, Jorgez C J, Matzuk M M. Growth differentiation factor 9 regulates expression of the bone morphogenetic protein antagonist, gremlin.  J Biol Chem. 2004;  279(31) 32281-32286
    CrossrefPubMedGoogle Scholar
  • 73 Sudo S, Avsian-Kretchmer O, Wang L S, Hsueh A J. Protein related to DAN and cerberus is a bone morphogenetic protein antagonist that participates in ovarian paracrine regulation.  J Biol Chem. 2004;  279(22) 23134-23141
    CrossrefPubMedGoogle Scholar
  • 74 Otsuka F, Moore R K, Iemura S, Ueno N, Shimasaki S. Follistatin inhibits the function of the oocyte-derived factor BMP-15.  Biochem Biophys Res Commun. 2001;  289(5) 961-966
    CrossrefPubMedGoogle Scholar
  • 75 Pierre A, Pisselet C, Monget P, Monniaux D, Fabre S. Testing the antagonistic effect of follistatin on BMP family members in ovine granulosa cells.  Reprod Nutr Dev. 2005;  45(4) 419-425
    CrossrefPubMedGoogle Scholar
  • 76 Millet C, Lemaire P, Orsetti B, Guglielmi P, Francois V. The human chordin gene encodes several differentially expressed spliced variants with distinct BMP opposing activities.  Mech Dev. 2001;  106(1-2) 85-96
    CrossrefPubMedGoogle Scholar
  • 77 Khokha M K, Hsu D, Brunet L J, Dionne M S, Harland R M. Gremlin is the BMP antagonist required for maintenance of Shh and Fgf signals during limb patterning.  Nat Genet. 2003;  34(3) 303-307
    PubMedGoogle Scholar
  • 78 McMahon J A, Takada S, Zimmerman L B, Fan C M, Harland R M, McMahon A P. Noggin-mediated antagonism of BMP signaling is required for growth and patterning of the neural tube and somite.  Genes Dev. 1998;  12(10) 1438-1452
    PubMedGoogle Scholar
  • 79 Bachiller D, Klingensmith J, Kemp C et al.. The organizer factors Chordin and Noggin are required for mouse forebrain development.  Nature. 2000;  403(6770) 658-661
    PubMedGoogle Scholar
  • 80 Nusslein-Volhard C, Wieschaus E. Mutations affecting segment number and polarity in Drosophila.  Nature. 1980;  287(5785) 795-801
    CrossrefPubMedGoogle Scholar
  • 81 Bitgood M J, Shen L, McMahon A P. Sertoli cell signaling by Desert hedgehog regulates the male germline.  Curr Biol. 1996;  6(3) 298-304
    CrossrefPubMedGoogle Scholar
  • 82 Wijgerde M, Ooms M, Hoogerbrugge J W, Grootegoed J A. Hedgehog signaling in mouse ovary: Indian hedgehog and desert hedgehog from granulosa cells induce target gene expression in developing theca cells.  Endocrinology. 2005;  146(8) 3558-3566
    CrossrefPubMedGoogle Scholar
  • 83 Gordon M D, Nusse R. Wnt signaling: multiple pathways, multiple receptors, and multiple transcription factors.  J Biol Chem. 2006;  281(32) 22429-22433
    CrossrefPubMedGoogle Scholar
  • 84 Uusitalo M, Heikkila M, Vainio S. Molecular genetic studies of Wnt signaling in the mouse.  Exp Cell Res. 1999;  253(2) 336-348
    CrossrefPubMedGoogle Scholar
  • 85 Vainio S, Heikkila M, Kispert A, Chin N, McMahon A P. Female development in mammals is regulated by Wnt-4 signalling.  Nature. 1999;  397 405-409
    CrossrefPubMedGoogle Scholar
  • 86 Ricken A, Lochhead P, Kontogiannea M, Farookhi R. Wnt signaling in the ovary: identification and compartmentalized expression of wnt-2, wnt-2b, and frizzled-4 mRNAs.  Endocrinology. 2002;  143(7) 2741-2749
    CrossrefPubMedGoogle Scholar
  • 87 Hsieh M, Johnson M A, Greenberg N M, Richards J S. Regulated expression of Wnts and Frizzleds at specific stages of follicular development in the rodent ovary.  Endocrinology. 2002;  143(3) 898-908
    CrossrefPubMedGoogle Scholar
  • 88 Hsieh M, Boerboom D, Shimada M et al.. Mice null for Frizzled4 (Fzd4 - / - ) are infertile and exhibit impaired corpora lutea formation and function.  Biol Reprod. 2005;  73(6) 1135-1146
    CrossrefPubMedGoogle Scholar
  • 89 Giles R H, van Es J H, Clevers H. Caught up in a Wnt storm: Wnt signaling in cancer.  Biochim Biophys Acta. 2003;  1653(1) 1-24
    PubMedGoogle Scholar
  • 90 Boerboom D, Paquet M, Hsieh M et al.. Misregulated Wnt/beta-catenin signaling leads to ovarian granulosa cell tumor development.  Cancer Res. 2005;  65(20) 9206-9215
    CrossrefPubMedGoogle Scholar
  • 91 Boerboom D, White L D, Dalle S, Courty J, Richards J S. Dominant-stable beta-catenin expression causes cell fate alterations and Wnt signaling antagonist expression in a murine granulosa cell tumor model.  Cancer Res. 2006;  66(4) 1964-1973
    CrossrefPubMedGoogle Scholar
  • 92 Artavanis-Tsakonas S, Rand M D, Lake R J. Notch signaling: cell fate control and signal integration in development.  Science. 1999;  284(5415) 770-776
    CrossrefPubMedGoogle Scholar
  • 93 Ehebauer M, Hayward P, Arias A M. Notch, a universal arbiter of cell fate decisions.  Science. 2006;  314(5804) 1414-1415
    CrossrefPubMedGoogle Scholar
  • 94 Swiatek P J, Lindsell C E, del Amo F F, Weinmaster G, Gridley T. Notch1 is essential for postimplantation development in mice.  Genes Dev. 1994;  8(6) 707-719
    CrossrefPubMedGoogle Scholar
  • 95 Hamada Y, Kadokawa Y, Okabe M, Ikawa M, Coleman J R, Tsujimoto Y. Mutation in ankyrin repeats of the mouse Notch2 gene induces early embryonic lethality.  Development. 1999;  126(15) 3415-3424
    PubMedGoogle Scholar
  • 96 Xue Y, Gao X, Lindsell C E et al.. Embryonic lethality and vascular defects in mice lacking the Notch ligand Jagged1.  Hum Mol Genet. 1999;  8(5) 723-730
    CrossrefPubMedGoogle Scholar
  • 97 Jiang R, Lan Y, Chapman H D et al.. Defects in limb, craniofacial, and thymic development in Jagged2 mutant mice.  Genes Dev. 1998;  12(7) 1046-1057
    PubMedGoogle Scholar
  • 98 Krebs L T, Xue Y, Norton C R et al.. Characterization of Notch3-deficient mice: normal embryonic development and absence of genetic interactions with a Notch1 mutation.  Genesis. 2003;  37(3) 139-143
    CrossrefPubMedGoogle Scholar
  • 99 Krebs L T, Xue Y, Norton C R et al.. Notch signaling is essential for vascular morphogenesis in mice.  Genes Dev. 2000;  14(11) 1343-1352
    PubMedGoogle Scholar
  • 100 Vorontchikhina M A, Zimmermann R C, Shawber C J, Tang H, Kitajewski J. Unique patterns of Notch1, Notch4 and Jagged1 expression in ovarian vessels during folliculogenesis and corpus luteum formation.  Gene Expr Patterns. 2005;  5(5) 701-709
    CrossrefPubMedGoogle Scholar
  • 101 Johnson J, Espinoza T, McGaughey R W, Rawls A, Wilson-Rawls J. Notch pathway genes are expressed in mammalian ovarian follicles.  Mech Dev. 2001;  109(2) 355-361
    CrossrefPubMedGoogle Scholar
  • 102 Hahn K L, Johnson J, Beres B J, Howard S, Wilson-Rawls J. Lunatic fringe null female mice are infertile due to defects in meiotic maturation.  Development. 2005;  132(4) 817-828
    CrossrefPubMedGoogle Scholar
  • 103 Zhang N, Gridley T. Defects in somite formation in lunatic fringe-deficient mice.  Nature. 1998;  394(6691) 374-377
    PubMedGoogle Scholar
  • 104 Evrard Y A, Lun Y, Aulehla A, Gan L, Johnson R L. lunatic fringe is an essential mediator of somite segmentation and patterning.  Nature. 1998;  394(6691) 377-381
    PubMedGoogle Scholar
  • 105 Xu J, Norton C R, Gridley T. Not all lunatic fringe null female mice are infertile.  Development. 2006;  133(4) 579-580
    PubMedGoogle Scholar
  • 106 Matzuk M M, Finegold M, Su J, Hsueh A, Bradley A. Alpha-inhibin is a tumor-suppressor gene with gonadal specificity in mice.  Nature. 1992;  360 313-319
    CrossrefPubMedGoogle Scholar
  • 107 Pieretti-Vanmarcke R, Donahoe P K, Szotek P et al.. Recombinant human Mullerian inhibiting substance inhibits long-term growth of MIS type II receptor-directed transgenic mouse ovarian cancers in vivo.  Clin Cancer Res. 2006;  12(5) 1593-1598
    CrossrefPubMedGoogle Scholar
  • 108 Niswander L, Jeffrey S, Martin G R, Tickle C. A positive feedback loop coordinates growth and patterning in the vertebrate limb.  Nature. 1994;  371(6498) 609-612
    CrossrefPubMedGoogle Scholar
  • 109 Kluppel M, Wrana J L. Turning it up a Notch: cross-talk between TGF beta and Notch signaling.  Bioessays. 2005;  27(2) 115-118
    CrossrefPubMedGoogle Scholar

Stephanie A PangasPh.D. 

Department of Pathology, Baylor College of Medicine

One Baylor Plaza S230, Houston, TX 77030

Email: spangas@bcm.edu

      >